This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...
Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part on these favorable ...
Bahrain has achieved a medical milestone by successfully treating a patient with sickle cell disease (SCD) using ...
The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient using ...
A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...
A student from Oxfordshire is going to be one of the first to receive a cutting-edge treatment for sickle ... chemistry in 2020. It works by editing the faulty gene in a patient's own stem cells.
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease ... the Nobel Prize for chemistry in 2020. It works by editing the faulty gene in a ...
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle ... for chemistry in 2020. It works by editing the faulty gene in a patient’s own stem cells.